Biotech, Food, Drug

The food we eat and the medicine we put into our bodies are highly regulated by a variety of government agencies. In the United States by the Food and Drug Administration (FDA) and the United States Department of Agriculture (USDA) regulate the processes by which food makes its way to the grocery store and medicine is approved for consumer use.  As the science grows more complex behind the pharmaceutical and food industry, interpretation of the regulations in place is becoming more nuanced.  Overseas, these industries are regulated by a variety of agencies; for example, the Minister of Agriculture in Canada, Centre for Food Safety in Hong Kong, and the Committee of Environmental, Public Health and Food Safety (EU), are among the many governing-bodies which regulate biotechnology, food, and drugs throughout the world.

The National Law Review is your free online resource to agency news, emerging topics in food and drug, and the latest in biotechnology updates. From nanotechnologies being used in research, to regulations of imported foods coming into the US from overseas or the development of medical devices and drugs, readers can find expert legal analysis of the developments in the industry, as well as reports on changes within the agencies that regulate these industries. The National Law Review also covers topics related to licensing, Food Safety and Inspection Services (FSIS), food and beverage regulation in the US and worldwide, nutrition labeling, and country of origin labeling guidelines.

With recent legislation being passed throughout the US in relation to marijuana use, both for recreational and medicinal purposes, readers will also find up-to-date information, litigation, and news coming from this area of interest as well. Regulations in California for labeling and proper sales of marijuana, to use in different states, or internationally, as well as rules for promoting and advertising marijuana are also covered on the site. Additionally, the development and changing landscape of tobacco use to include vaping, and how e-cigarettes and vaping are regulated, is also covered by NLR authors.

Readers who are interested in food safety, inspection, imports into the US, and regulations, these topics are covered regularly on The National Law Review as well. New legislation from the FDA, USDA, Department of Agriculture, and international bodies, are covered on the site. If you are looking for details on new nutrition-labeling regulations or health risks of consuming certain imported foods, you will find these topics, and many more, on The National Law Review.

For hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis Twitter feed, and sign up for complimentary e-news bulletins.

Custom text Title Organization Sort descending
Aug
15
2018
Will Federal Special Registration Exception Preempt More Stringent State Rules on Remote Prescribing of Controlled Substances? Epstein Becker & Green, P.C.
Dec
20
2018
Marijuana Legalization Takes Another Step Forward in 2018 Elections Epstein Becker & Green, P.C.
Jan
4
2022
Unpacking Averages: Likelihood of FDA Medical Device Inspections Epstein Becker & Green, P.C.
Jan
25
2019
FDA Embraces Role in Managing Medical Device Cybersecurity Risk by Issuing New Guidance Epstein Becker & Green, P.C.
Jan
19
2022
Video: SCOTUS Decides on Vaccine Rules, Companies Can Still Require Vaccination, Restrictive Covenants in CO – Employment Law This Week Epstein Becker & Green, P.C.
Mar
4
2019
OIG Evaluates Remote Patient Monitoring Arrangement Epstein Becker & Green, P.C.
Jan
27
2015
Will Promoted Video Pave the Way for Drug and Medical Device Promotion on Twitter? Epstein Becker & Green, P.C.
Apr
13
2015
Supreme Court Rules That Providers and Suppliers Cannot Challenge Medicaid Reimbursement Rates in Federal Court Epstein Becker & Green, P.C.
Oct
20
2015
D.C. District Court Vacates HRSA’s Interpretative Rule on Orphan Drugs Epstein Becker & Green, P.C.
Dec
14
2015
California Imposes Controversial Cost-Sharing Restrictions to Facilitate Patient Access to Expensive Drugs Epstein Becker & Green, P.C.
Mar
19
2020
OCR Waives Penalties for Telehealth Communications During COVID-19 National Emergency Epstein Becker & Green, P.C.
Aug
1
2023
FDA’s LDT Proposed Rule Heads to the White House Epstein Becker & Green, P.C.
Sep
5
2023
State Regulation of Pharmacy Benefit Managers: Tenth Circuit Holds That ERISA and Medicare Part D Preempt Key Parts of Oklahoma PBM Law Epstein Becker & Green, P.C.
Nov
20
2023
Sharing Scientific Information with HCPs on Unapproved Uses of Medical Products: Dos and Don’ts Under FDA’s New Draft Guidance Epstein Becker & Green, P.C.
Aug
12
2020
Be Aware Before You Share: Vetting Third Party Apps Prior to Data Transfer Epstein Becker & Green, P.C.
Mar
7
2024
Making Moves – FDA’s LDT Proposed Rule Sent to OMB for Review Epstein Becker & Green, P.C.
Feb
16
2018
White House 2019 Budget and White Paper Shape Ambitious Policy to Reduce Drug Prices Epstein Becker & Green, P.C.
Jun
3
2021
Federal and State Cannabis Rules Are Moving in Different Directions – Diagnosing Health Care [PODCAST] Epstein Becker & Green, P.C.
Nov
20
2018
FDA Loosens the Reins on Informed Consent Requirements for Certain Clinical Studies Epstein Becker & Green, P.C.
Dec
16
2021
CMS Issues Guidance on COVID-19 Testing in the Workplace Epstein Becker & Green, P.C.
Feb
3
2015
Are Lower Cost Drugs Less Effective? It May Depend on the Patient’s Perspective. Epstein Becker & Green, P.C.
Feb
12
2015
Prescribing and Telemedicine: The “Physical” Exam Epstein Becker & Green, P.C.
Aug
14
2019
What’s New in E-Cigarette Regulation? Epstein Becker & Green, P.C.
Sep
13
2019
The FDA Looks Inward as It Tackles Interoperability Epstein Becker & Green, P.C.
Aug
28
2015
Health Resources and Service Administration (HRSA) Issues Proposed “Omnibus Guidance” Epstein Becker & Green, P.C.
Mar
12
2020
NJ Supreme Court Rules that the LAD Protects Registered Medical Cannabis Users Epstein Becker & Green, P.C.
Sep
5
2023
FDA Issues Final Guidance on Informed Consent for IRBs, Clinical Investigators, and Sponsors Epstein Becker & Green, P.C.
Mar
19
2024
FDA and OHRP Issue Joint Draft Guidance on Content, Organization, and Presentation of Consent Forms for Research Participants Epstein Becker & Green, P.C.
Nov
6
2020
Get Out the Toke: State Ballot Initiatives Legalize Marijuana and More Epstein Becker & Green, P.C.
Jan
22
2018
New State Laws Allow Telehealth Prescriptions for Controlled Substances; Yet, Regulatory Obstacles Still Remain Epstein Becker & Green, P.C.
Jul
11
2018
State Attorneys General Investigating Use of Non-Competes by Fast Food Franchisors Epstein Becker & Green, P.C.
Oct
19
2018
New Federal Laws Banning “Gag Clauses” in the Pharmacy Epstein Becker & Green, P.C.
Jun
22
2022
The Pendulum Swings Both Ways: State Responses to Protect Reproductive Health Data, Post-Roe Epstein Becker & Green, P.C.
Jan
27
2015
Telemedicine has an Unlikely Ally: The Federal Trade Commission (FTC) Epstein Becker & Green, P.C.
Mar
7
2023
The Wait is Over . . . Or Is It? DEA’s Proposed Rules Around Telemedicine Prescribing: Initial Impressions and Key Takeaways Epstein Becker & Green, P.C.
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins